Shanghai Zhongshan Hospital: Diabetes Mellitus trials

The registry lists 13 Diabetes Mellitus studies with Shanghai Zhongshan Hospital as lead sponsor. 4 are open to participants now and 0 have results posted.

Early Phase 1 2Phase 4 2No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral AgentsRecruitingNCT07307235Phase 4
• Autologous Islet Transplantation for DiabetesEnrolling by invitationNCT07118475Early Phase 1
• Observational Analysis of the Associational Between Dietary Factors and Postprandial Glucose FluctuationsNot yet recruitingNCT07117188
• A Prospective Multicenter Clinical Study： IntracOronary neaR-Infrared Spectroscopy and OptIcal Coherence Tomography for Evaluating Coronary vulNerable Plaque in Patients With diabeTesRecruitingNCT06649305
• Clinical Study on the Safety and Efficacy of Immunophenotyped Pancreatic Endocrine Organoid Bank in Treating Patients With T3c DiabetesActive, not recruitingNCT06991829Early Phase 1
• Explainable Insulin Decision-making System to Assist Physicians in Diabetes ManagementCompletedNCT06434584
• Artificial Intelligence-assisted Insulin System in Type 2 Diabetes in General WardsCompletedNCT06319300Not applicable
• Insulin Titration System Based on Deep LearningCompletedNCT05409391Not applicable
• Long-term Effect of Moderate and Vigorous Exercise on Incident Diabetes in Obese SubjectsCompletedNCT05346250
• Study to Assess the Efficacy and Safety of iNCDSS in Type 2 Diabetes Mellitus PatientsCompletedNCT04642378Not applicable
• Effect of Dulaglutide on Glycemic Variability in Patients With Type 2 DiabetesCompletedNCT04374578
• The Prognostic Value of Lactate is Different Among Septic PatientsCompletedNCT04155060
• Remission of Type 2 Diabetes With Dapagliflozin (READ Trial)CompletedNCT04004793Phase 4